Tulmimetostat

Tulmimetostat (CPI-0209) is an orally bioavailable and selective inhibitor of EZH2 that has therapeutic potential for androgen receptor-dependent prostate cancer.
Supplier Selleck Chemicals
Product # E1497
Sku # E1497-5mg
Pricing 5mg, $79.00
Feedback